Photo credit: www.sciencedaily.com
Potential of Resveratrol in Enhancing Female Fertility: A Systematic Review
Recent findings emphasize the promising role of resveratrol, a natural compound found in the skin of various fruits such as grapes, blueberries, and raspberries, in enhancing female fertility.
This comprehensive systematic review examined the effects of resveratrol on female reproductive health and has been published in the International Journal of Molecular Sciences. The research team, comprising experts from Anglia Ruskin University (ARU) in Cambridge, in collaboration with institutions from Italy, South Korea, and the Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust, explored previously published works related to this topic.
By synthesizing data from 24 in vitro and in vivo studies that together involved over 9,500 human participants, the researchers uncovered evidence suggesting that resveratrol may improve both the quantity and quality of oocytes, or egg cells.
Among the studies analyzed, four specifically addressed the number of matured oocytes. Results were mixed: two studies indicated an increase in oocyte quantity, while the other two found no discernible difference. When focusing on oocyte quality, two additional studies consistently reported improvements among women who incorporated resveratrol into their regimen.
The mechanism behind these potential benefits could be attributed to resveratrol’s ability to diminish oxidative stress, thereby protecting mitochondrial DNA from damage and enhancing telomerase activity, which may help slow cellular aging. Additionally, resveratrol is known to activate sirtuin 1 (SIRT1), a molecule that generally declines in aged oocytes, potentially promoting healthier cellular aging and a longer ovarian lifespan.
The review further indicated that resveratrol might have therapeutic applications for infertility conditions related to endometriosis. It appears to positively impact polycystic ovary syndrome and obesity-related infertility by inhibiting pathways associated with androgen production, while also reducing inflammation and oxidative stress.
However, the findings regarding miscarriage and pregnancy outcomes were mixed. Out of five studies analyzing pregnancy rates, two showed a rise, two reported no change, and one indicated a decrease in pregnancies amongst individuals taking resveratrol. Notably, the same study that documented a decline in pregnancy rates also observed an increase in miscarriage rates, whereas another study reported no differences.
Consumption of resveratrol is generally regarded as safe when taken in moderate dietary amounts or through supplements, with an upper limit of five grams a day for a month. Nevertheless, the safety implications of high-dose supplementation, particularly over extended periods, remain uncertain.
Professor Lee Smith, a public health expert at Anglia Ruskin University and the senior author of the paper, stated: “Our systematic review provides a thorough overview of existing research on resveratrol and female fertility, highlighting the compound’s potential to enhance reproductive outcomes and possibly initiate the development of new, less invasive treatments utilizing natural substances.”
Yet, he cautioned that the findings come with certain limitations. These include a limited number of human studies, variability in research parameters, and insufficient robust data regarding dosages and side effects, particularly concerning potential birth defects or fetal abnormalities. “There is a pressing need for further clinical trials involving human participants to transform these encouraging results into actionable recommendations for women seeking to improve their fertility, including advice on the safe and effective use of resveratrol,” Smith concluded.
Source
www.sciencedaily.com